BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 12526705)

  • 1. Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy.
    Shukla S; Wu G; Chatterjee M; Yang W; Sekido M; Diop LA; Müller R; Sudimack JJ; Lee RJ; Barth RF; Tjarks W
    Bioconjug Chem; 2003; 14(1):158-67. PubMed ID: 12526705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
    Singh P; Gupta U; Asthana A; Jain NK
    Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
    Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
    J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP; Cooper SR; Hardee GE
    Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes.
    Pan XQ; Wang H; Lee RJ
    Anticancer Res; 2002; 22(3):1629-33. PubMed ID: 12168846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery.
    Chandrasekar D; Sistla R; Ahmad FJ; Khar RK; Diwan PV
    J Biomed Mater Res A; 2007 Jul; 82(1):92-103. PubMed ID: 17269145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
    Stephenson SM; Yang W; Stevens PJ; Tjarks W; Barth RF; Lee RJ
    Anticancer Res; 2003; 23(4):3341-5. PubMed ID: 12926073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting.
    Choi Y; Thomas T; Kotlyar A; Islam MT; Baker JR
    Chem Biol; 2005 Jan; 12(1):35-43. PubMed ID: 15664513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and grafting of folate-PEG-PAMAM conjugates onto quantum dots for selective targeting of folate-receptor-positive tumor cells.
    Zhao Y; Liu S; Li Y; Jiang W; Chang Y; Pan S; Fang X; Wang YA; Wang J
    J Colloid Interface Sci; 2010 Oct; 350(1):44-50. PubMed ID: 20624622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
    Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
    Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy.
    Masunaga S; Kasaoka S; Maruyama K; Nigg D; Sakurai Y; Nagata K; Suzuki M; Kinashi Y; Maruhashi A; Ono K
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1515-22. PubMed ID: 17126210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents.
    Yang W; Barth RF; Wu G; Tjarks W; Binns P; Riley K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S328-31. PubMed ID: 19467880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
    Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled PEGylated dendrimer poly(amidoamine) (PAMAM)-folic acid conjugates.
    Zhang Y; Sun Y; Xu X; Zhang X; Zhu H; Huang L; Qi Y; Shen YM
    J Med Chem; 2010 Apr; 53(8):3262-72. PubMed ID: 20350006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
    Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
    Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.